Pure Bioscience Announces Results of 2025 Annual Meeting of Stockholders

PURE BIOSCIENCE, INC.

Stockholders elected all seven director nominees with approval ranging from 95.59% to 98.18%.
Ratified Weinberg & Company as independent auditor for fiscal year ending July 31, 2025, with 99.19% approval.
Approved executive compensation on a non-binding advisory basis with 95.49% of votes cast.
61,264,581 shares (54.77% of outstanding) were represented at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.